Success Metrics

Clinical Success Rate
93.5%

Based on 43 completed trials

Completion Rate
93%(43/46)
Active Trials
10(15%)
Results Posted
35%(15 trials)
Terminated
3(4%)

Phase Distribution

Ph phase_2
15
22%
Ph not_applicable
16
24%
Ph phase_3
12
18%
Ph phase_4
17
25%
Ph phase_1
2
3%

Phase Distribution

2

Early Stage

15

Mid Stage

29

Late Stage

Phase Distribution62 total trials
Phase 1Safety & dosage
2(3.2%)
Phase 2Efficacy & side effects
15(24.2%)
Phase 3Large-scale testing
12(19.4%)
Phase 4Post-market surveillance
17(27.4%)
N/ANon-phased studies
16(25.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.5%

43 of 47 finished

Non-Completion Rate

8.5%

4 ended early

Currently Active

10

trials recruiting

Total Trials

67

all time

Status Distribution
Active(14)
Completed(43)
Terminated(4)
Other(6)

Detailed Status

Completed43
Recruiting7
unknown6
Not yet recruiting3
Active, not recruiting3
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
67
Active
10
Success Rate
93.5%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (3.2%)
Phase 215 (24.2%)
Phase 312 (19.4%)
Phase 417 (27.4%)
N/A16 (25.8%)

Trials by Status

not_yet_recruiting34%
active_not_recruiting34%
completed4364%
recruiting710%
enrolling_by_invitation11%
terminated34%
withdrawn11%
unknown69%

Recent Activity

Clinical Trials (67)

Showing 20 of 67 trialsScroll for more
NCT06807164Phase 2

Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome

Recruiting
NCT07470164Phase 3

Botulinum Toxin A vs Strabismus Surgery for Esotropia

Not Yet Recruiting
NCT06212661

Migraine Medication Effects on Urinary Symptoms

Enrolling By Invitation
NCT05430893

Intra-muscular Botulinum Toxin A in Chronic Athletic Pubalgia

Completed
NCT03187626Phase 2

Efficacy of an Intra-articular Injection of Botulinum Toxin A Associated With Splinting for Base-of-thumb Osteoarthritis

Completed
NCT03985982Phase 3

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII)

Completed
NCT05367271Phase 2

The Efficacy of Botulinum Toxin vs. Corticosteroid for the Treatment of Refractory Plantar Fasciitis

Completed
NCT02677298Phase 3

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I

Completed
NCT02677805Phase 3

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II

Completed
NCT06878482Phase 4

Effect of Blood Flow by Botulinum Toxin Injection for Severe Peripheral Artery Occlusive Disease

Recruiting
NCT06814288Phase 2

The Effectiveness of Intralesional Botulinum Toxin A and Triamcinolone Acetonide Injections in Keloid Treatment

Active Not Recruiting
NCT01688076Phase 4

Treatment of Forehead/Glabellar Rhytide Complex With Botulinum Toxin A Injection

Active Not Recruiting
NCT02216838Phase 4

Treatment of Facial Flushing With Botulinum Toxin A Injections

Active Not Recruiting
NCT02196155Not Applicable

Botulinum Toxin A Versus Steroids for the Treatment of Chronic Plantar Fasciitis

Recruiting
NCT06583590Phase 2

Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction

Recruiting
NCT06684249Not Applicable

Efficacy of Nerve Block Versus Botox in Chronic Migraine Management

Recruiting
NCT06218316Not Applicable

Repetitive Transcranial Magnetic Stimulation Versus Botulinum Injection on Spasticity on Children With Diplegic Cerebral Palsy

Completed
NCT06556030Phase 4

A Multicentre, Randomised, Single-blind, Controlled Protocol to Evaluate the Efficacy of Early Administration of Botulinum Toxin for Primary Midline Closure in Patients With Open Abdomen.

Not Yet Recruiting
NCT05426161Phase 4

The Effect of Subcutaneous Injection of Botulinum Toxin A on Chronic Wound Pain in Lower Extremities

Completed
NCT06470581Not Applicable

Thoracic Sympathetic Ganglion Block With Botulinum Toxin Type A

Not Yet Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
67